Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Jul-24 8:00 PM View:  | Intra-Cellular Therapies, I... (ITCI) | 28-Jun-24 | Grant | 83 | $68.49 | $5,684.67 | < 1% 11.26K to 11.34K | |
| 25-Jun-24 6:05 PM View: | Intra-Cellular Therapies, I... (ITCI) | 23-Jun-24 | Option Exercise | 1,567 | -- | -- | 16% 9.69K to 11.26K | |
| 21-Jun-24 6:00 PM View: | Intra-Cellular Therapies, I... (ITCI) | 18-Jun-24 | Option Exercise | 20,000 | $16.86 | $337,200.00 | 206% 9.69K to 29.69K | |
| 21-Jun-24 6:00 PM View: | Intra-Cellular Therapies, I... (ITCI) | 18-Jun-24 | Planned Option Sale | 20,000 | $75.91 | $1,518,200.00 | (67%) 29.69K to 9.69K | |
| 02-Apr-24 4:15 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Mar-24 | Grant | 79 | $69.20 | $5,466.80 | < 1% 9.61K to 9.69K | |
| 01-Apr-24 11:52 AM View: | Metabolix, Inc. (YTEN) | 28-Mar-24 | Grant | 11,924 | -- | -- | 32% 36.71K to 48.63K | |
| 28-Feb-24 7:41 PM View: | Intra-Cellular Therapies, I... (ITCI) | 27-Feb-24 | Option Exercise | 20,000 | $18.56 | $371,200.00 | 208% 9.61K to 29.61K | |
| 28-Feb-24 7:41 PM View: | Intra-Cellular Therapies, I... (ITCI) | 27-Feb-24 | Option Sale | 20,000 | $72.93 | $1,458,650.00 | (68%) 29.61K to 9.61K | |
| 25-Jan-24 6:00 AM View: | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 6,000 | -- | -- | 136% 4.4K to 10.4K | |
| 03-Jan-24 6:43 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Dec-23 | Grant | 76 | $71.62 | $5,443.12 | < 1% 9.54K to 9.61K | |
| 03-Jan-24 4:35 PM View: | Metabolix, Inc. (YTEN) | 29-Dec-23 | Grant | 18,879 | -- | -- | 106% 17.83K to 36.71K | |
| 02-Oct-23 10:00 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Sep-23 | Grant | 105 | $52.09 | $5,469.45 | 1% 9.43K to 9.54K | |
| 02-Oct-23 3:41 PM View: | Metabolix, Inc. (YTEN) | 29-Sep-23 | Grant | 13,868 | -- | -- | 350% 3.96K to 17.83K | |
| 05-Jul-23 1:24 PM View: | Metabolix, Inc. (YTEN) | 30-Jun-23 | Grant | 2,040 | -- | -- | 106% 1.92K to 3.96K | |
| 05-Jul-23 4:29 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Jun-23 | Grant | 85 | $63.32 | $5,382.20 | < 1% 9.35K to 9.43K | |
| 19-Apr-23 6:00 PM View: | Intra-Cellular Therapies, I... (ITCI) | 17-Apr-23 | Option Exercise | 10,000 | $13.05 | $130,500.00 | 107% 9.35K to 19.34K | |
| 19-Apr-23 6:00 PM View: | Intra-Cellular Therapies, I... (ITCI) | 17-Apr-23 | Planned Option Sale | 10,000 | $63.00 | $630,000.00 | (52%) 19.34K to 9.35K | |
| 04-Apr-23 5:24 PM View: | Metabolix, Inc. (YTEN) | 31-Mar-23 | Grant | 1,642 | -- | -- | 582% 0.28K to 1.92K | |
| 04-Apr-23 5:03 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Mar-23 | Grant | 95 | $54.15 | $5,144.25 | 1% 9.25K to 9.35K | |
| 03-Feb-23 5:11 PM View: | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 2,500 | -- | -- | 132% 1.9K to 4.4K | |
| 03-Jan-23 4:19 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Dec-22 | Grant | 97 | $52.92 | $5,133.24 | 1% 9.15K to 9.25K | |
| 05-Oct-22 4:04 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Sep-22 | Grant | 110 | $46.53 | $5,118.30 | 1% 9.04K to 9.15K | (12%) |
| 12-Aug-22 6:09 PM View: | Intra-Cellular Therapies, I... (ITCI) | 11-Aug-22 | Option Exercise | 30,000 | $12.65 | $379,500.00 | 332% 9.04K to 39.04K | |
| 12-Aug-22 6:09 PM View: | Intra-Cellular Therapies, I... (ITCI) | 11-Aug-22 | Option Sale | 30,000 | $57.13 | $1,713,980.00 | (77%) 39.04K to 9.04K | |
| 05-Jul-22 4:08 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Jun-22 | Grant | 108 | $57.08 | $6,164.64 | 1% 8.94K to 9.04K | |
| 04-Apr-22 4:11 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Mar-22 | Grant | 126 | $61.19 | $7,709.94 | 1% 8.81K to 8.94K | |
| 01-Feb-22 5:06 PM View: | Galena Biopharma, Inc. (SLS) | 31-Jan-22 | Grant | 1,900 | -- | -- | 100% 0 to 1.9K | |
| 04-Jan-22 10:00 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Dec-21 | Grant | 148 | $52.34 | $7,746.32 | 2% 8.66K to 8.81K | (14%) |
| 04-Oct-21 4:23 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Sep-21 | Grant | 215 | $37.28 | $8,015.20 | 3% 8.45K to 8.66K | 3% |
| 02-Jul-21 4:55 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Jun-21 | Grant | 173 | $40.82 | $7,061.86 | 2% 8.27K to 8.45K | 4% |
| 02-Apr-21 5:26 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Mar-21 | Grant | 208 | $33.93 | $7,057.44 | 3% 8.06K to 8.27K | < 1% |
| 05-Jan-21 6:05 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Dec-20 | Grant | 222 | $31.80 | $7,059.60 | 3% 7.84K to 8.06K | (< 1%) |
| 02-Oct-20 4:24 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Sep-20 | Grant | 276 | $25.66 | $7,082.16 | 4% 7.57K to 7.84K | 22% |
| 02-Jul-20 7:12 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Jun-20 | Grant | 275 | $25.67 | $7,059.25 | 4% 7.29K to 7.57K | 22% |
| 02-Apr-20 5:55 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Mar-20 | Grant | 460 | $15.37 | $7,070.20 | 7% 6.83K to 7.29K | 104% |
| 29-Jan-20 4:16 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 40,000 | $6.30 | $252,000.00 | (100%) 40.0K to 0 | |
| 03-Jan-20 9:13 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Dec-19 | Grant | 170 | $34.31 | $5,832.70 | 3% 6.66K to 6.83K | (9%) |
| 19-Dec-19 5:33 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 18-Dec-19 | Option Exercise | 20,000 | $3.28 | $65,600.00 | 100% 20.0K to 40.0K | |
| 02-Oct-19 5:32 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Sep-19 | Grant | 780 | $7.47 | $5,826.60 | 13% 5.88K to 6.66K | 320% |
| 02-Jul-19 5:17 PM View: | Intra-Cellular Therapies, I... (ITCI) | 28-Jun-19 | Grant | 449 | $12.98 | $5,828.02 | 8% 5.43K to 5.88K | 142% |
| 02-Apr-19 6:59 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Mar-19 | Grant | 478 | $12.18 | $5,822.04 | 10% 4.96K to 5.43K | 158% |
| 03-Jan-19 8:19 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Dec-18 | Grant | 512 | $11.39 | $5,831.68 | 12% 4.44K to 4.96K | 176% |
| 18-Dec-18 4:22 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 14-Dec-18 | Option Exercise | 20,000 | $1.05 | $21,000.00 | 100% 0 to 20.0K | |
| 02-Oct-18 8:06 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Sep-18 | Grant | 268 | $21.70 | $5,815.60 | 6% 4.17K to 4.44K | |
| 03-Jul-18 4:22 PM View: | Intra-Cellular Therapies, I... (ITCI) | 29-Jun-18 | Grant | 282 | $17.67 | $4,982.94 | 7% 3.89K to 4.17K | |
| 03-Apr-18 4:19 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Mar-18 | Grant | 237 | $21.05 | $4,988.85 | 6% 3.66K to 3.89K | |
| 03-Jan-18 4:31 PM View: | Intra-Cellular Therapies, I... (ITCI) | 29-Dec-17 | Purchase | 345 | $14.48 | $4,995.60 | 10% 3.31K to 3.66K | |
| 03-Oct-17 6:19 PM View: | Intra-Cellular Therapies, I... (ITCI) | 29-Sep-17 | Grant | 316 | -- | -- | 11% 3.0K to 3.31K | |
| 05-Jul-17 4:19 PM View: | Metabolix, Inc. (YTEN) | 30-Jun-17 | Grant | 3,519 | -- | -- | 45% 7.77K to 11.29K | |
| 05-Jul-17 6:07 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Jun-17 | Grant | 402 | -- | -- | 16% 2.59K to 3.0K |